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Doarctectomy reduces neoaortic arch obstruction in
ypoplastic left heart syndrome
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540 The Journal of Thoracic and Cardbjective: Neoaortic arch obstruction after stage I palliation is an important risk
actor affecting interstage mortality in patients with hypoplastic left heart syndrome,
ith no accepted standard surgical approach. We sought to determine the efficacy
f different techniques for aortic arch reconstruction to reduce the incidence of
ostoperative neoaortic arch obstruction.
ethods: From January 2000 through June 2005, 210 patients underwent stage I
alliation. To enlarge the aortic arch, 12 (6%) patients had a direct connection, 115
55%) patients had an aortic homograft, 53 (25%) patients had a pulmonary
omograft patch, and 30 (14%) patients had autologous pericardium. Independent of
he technique for aortic enlargement, 55 (26%) children had coarctectomy.
esults: Eighty patients had a significant arch gradient, as determined by means of
chocardiography, and of these, 50 required balloon angioplasty, surgical arch
ugmentation, or both. Preoperative aortic coarctation was consistently linked to
eoaortic arch obstruction (P  .032). Patients having aortic arch enlargement by
eans of direct connection or with autologous pericardium were less likely to have
eoaortic arch obstruction (P  .049). Coarctectomy resulted in a lower incidence
f neoaortic arch obstruction, as determined by means of echocardiography (P 
015), or need for reintervention (P  .01).
onclusions: Patients with hypoplastic left heart syndrome undergoing aortic arch
nlargement with autologous tissue are less likely to require intervention for
eoaortic arch obstruction compared with those having homograft patch reconstruc-
ion. Excision of all ductal tissue by means of coarctectomy reduces the risk of
ecurrent aortic arch obstruction. An aggressive approach to reconstruction of the
rch and the use of autologous tissue at the time of stage I palliation is advocated.
ypoplastic left heart syndrome (HLHS) is the most frequently encountered
congenital heart malformation characterized by a single well-developed
ventricle. Its incidence is about 7% of all infants presenting with cardiac
isease in the first year of life.1 HLHS involves a wide spectrum of underdevel-
ent of the left-sided heart structures, characterized by aortic and/or mitral valve
tresia or severe stenosis with hypoplasia or absence of the left ventricle.2,3 Coarc-
ation of the aorta is usually associated with the anomaly.4,5 The first successfu
alliative operation for this complex cardiac anomaly was reported by Norwood and
olleagues in 1983.6 The surgical technique achieved reconstruction of the ao
rch by means of direct anastomosis between the pulmonary artery trunk and the
iminutive aorta. Although this procedure has been advocated recently by some
roups,7-10 it was abandoned by Norwood and others because surgical anatomy
ot usually deemed suitable to carry out this approach, with recurrent arch obstruc-
ion and left pulmonary artery stenosis being frequently observed. Augmentation of
he aorta and arch remains a critical step in the Norwood operation, and surgical
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Dechnical problems have been reported as the leading cause
f sudden circulatory arrest and death early after the Nor-
ood operation.11,12 Neoaortic arch obstruction (NAO) 
ne of the key features affecting morbidity and mortality
fter the stage I palliation or Norwood operation, with a
eported incidence ranging from 11% to 37%.13-17 Recur-
ent arch obstruction can result in decreased cardiac output,
entricular dysfunction, and tricuspid regurgitation. How-
ver, there is not a standard surgical approach for the
econstruction of the aorta at the time of stage I palliation.
The aim of this study was to compare the various surgi-
al techniques used to augment the aortic arch at the time of
he stage I procedure with respect to recurrence of NAO and




e retrospectively reviewed all patients undergoing a stage I
alliation procedure at Children’s Hospital Boston from January
000 through June 2005. The diagnosis for HLHS was based on
chocardiographic evidence of diminutive ascending aorta, aortic
tresia or stenosis, mitral atresia or stenosis, and hypoplastic left
entricle. Patients with anatomic variants of HLHS who underwent
tage I palliation were also included in our study population.
reoperative evaluation of the aortic arch was performed by using
chocardiography. Coarctation was defined as the presence of a
atent posterior shelf in the ductal area. Evaluation of the aortic
rch was done with echocardiography at the time of the pre–stage
I echocardiogram or most recent echocardiography in the patients
ho had not had the stage II procedure. A persistent mean systolic
radient across the arch equal to or greater than 15 mm Hg was
onsidered significant. Need for balloon angioplasty or surgical
ortic arch reconstruction was also recorded. The decision for
eintervention was made on the basis of echocardiographic gradi-
nts plus catheterization or magnetic resonance imaging data. This
tudy was approved by the Children’s Hospital Boston Institu-
ional Review Board.
urgical Procedure
he surgical procedure for coarctectomy entails resection of the
orta at the level of coarctation, wide resection of all the ductal
issue and the posterior shelf, extended counterincision distally in
he anterolateral aspect of the descending thoracic aorta, mobili-
ation of the supra-aortic trunks, and direct end-to-end anastomo-
is between the greater curvature of the native aortic arch and the
escending aorta, along with patch augmentation of the aorta with
utologous pericardium treated with glutaraldehyde 4% for 10
Abbreviations and Acronyms
HLHS hypoplastic left heart syndrome
NAO  neoaortic arch obstructioninutes or heterologous tissue. i
The Journal of ThoracicRegardless of the surgeon’s preferences, in the vast majority of
atients, our approach for HLHS entails deep hypothermic circu-
atory arrest, with pH-stat for less than 28°C and a hematocrit
alue of greater than 25%. One hundred forty-four patients in our
eries underwent delayed sternal closure.
tatistical Analysis
he 2 primary outcome variables were recurrence of NAO and
eed for balloon dilation, repeat surgical reconstruction, or both,
nd a secondary outcome variable was in-hospital mortality. Re-
ationships between patient and surgical characteristics and out-
omes were evaluated by using the Fisher exact test. Multivariate
nalyses were performed with logistic regression. As part of the
ultivariate analysis, interactions among variables included in the
ogistic regression model were explored.
esults
etween January 2000 and June 2005, 220 patients with
LHS underwent a stage I palliation at Children’s Hospital
oston. This time period was chosen because it represents
ur recent experience, but more importantly, it includes a
ufficiently large cohort of patients to permit meaningful
tatistical comparisons. Postoperative echocardiographic
ata on the aortic arch were not available in 10 patients, and
herefore they were excluded from the study. The remaining
10 patients constitute our final study population. There
ere 128 (61%) male and 82 (39%) female patients. Median
ge and weight at the time of stage I palliation were 5 days
range, 1-373 days) and 3.2 kg (range, 1.3-4.5 kg), respec-
ively. The morphologic subgroups were aortic and mitral
tresia in 47 (22%) patients, aortic atresia and mitral steno-
is in 39 (19%) patients, aortic stenosis and mitral atresia in
(4%) patients, aortic and mitral stenosis in 62 (30%)
atients, and HLHS anatomic variant in 54 (26%) patients.
he presence of a posterior shelf at the distal aortic arch was
emonstrated by means of echocardiography in 90 (43%)
atients. One hundred fifty-three (73%) patients had a mod-
fied Blalock–Taussig shunt at the time of stage I palliation,
nd 57 (27%) patients had a right ventricle–to–pulmonary
rtery shunt. Aortic arch augmentation was performed with
n aortic homograft in 115 (55%) patients, a pulmonary
omograft in 53 (25%) patients, autologous pericardium in
0 (14%) patients, and direct pulmonary-to-aorta connec-
ion in 12 (6%) patients.
At a median follow-up of 1.7 years (range, 4 days-5.7
ears) 172 (82%) patients are alive, 170 (81%) patients have
ad a stage II palliation, and 84 (40%) patients have com-
leted stage III of palliation. Twenty (10%) of the 210
atients died in the hospital. Interstage mortality was 6%
13 patients). Weight at the time of the operation of less than
kg was significantly associated with early postoperative
eath (P  .001); overall mortality for patients weighing 3
g or greater was 4% (6/136), whereas it was 19% (14/73)
n patients weighing less than 3 kg at the time of the stage
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Doperation. There was also higher mortality in patients with
ortic atresia–mitral stenosis (P  .030). In the multivariate
nalysis weight at the time of the operation of less than 3 kg
P  .002) and aortic atresia–mitral stenosis (P  .023)
ere risk factors for death, with odds ratios of 5.0 and 3.3,
espectively.
The incidence of a significant gradient, as determined by
eans of echocardiography, across the aortic arch after
tage I palliation was 38% (80/210). Of these patients, 50
24%) had either balloon dilation, aortic arch augmentation,
r both at follow-up. Factors significantly and inversely
elated to postoperative NAO on the basis of results of
chocardiography or need for intervention were use of au-
ologous material to enlarge the aortic arch and coarctec-
omy. In this latter group 20 patients received autologous
ericardium for reconstruction of the aortic arch, 18 re-
eived a pulmonary homograft patch, 12 received an aortic
omograft patch, and 5 underwent direct anastomosis be-
ween the aorta and the pulmonary trunk. Interestingly,
hunt type or size was not related to development of NAO.
nivariate and multivariate analysis are shown in Tabl
nd 2. In multivariate analysis statistically significant in
ctions between aortic coarctation and resection of the pos-
erior shelf were detected; resection of the posterior shelf
as associated with outcome in patients with aortic coarc-
ation and not associated with outcome among those without
ortic coarctation. The effect of coarctectomy is shown in
able 3.
iscussion
n this study we found that recurrent aortic arch obstruction
ccurred in 24% to 38% of infants after first-stage palliation
or HLHS, depending on whether significant obstruction is
efined by the need for arch intervention or by echocardio-
raphic criteria, respectively. Thirty patients in our series
ith borderline diagnoses of NAO determined by means of
chocardiography did not receive either balloon angioplasty
r surgical arch reconstruction, depending on confirmation
f the aortic arch gradient in the catheterization laboratory.
oarctectomy, use of autologous material for arch recon-
truction, or primary connection of the pulmonary trunk to
he aorta significantly reduced the incidence of recurrent
rch obstruction after the Norwood procedure. Inversely,
se of a homograft, especially an aortic wall homograft
atch, for arch reconstruction was associated with a higher
ncidence of arch obstruction after first-stage palliation.
HLHS is marked by underdevelopment of the left-sided
eart structures, including the aortic arch. The goal of the
rst stage of surgical palliation is to create a large and
nobstructed pathway for systemic circulation. A wide va-
iety of materials have been used to enlarge the aortic
rch.13-17 Currently, the more common technique for a
ugmentation in the Norwood operation includes the use of b
542 The Journal of Thoracic and Cardiovascular Surgery ● Junheterologous tissue to augment the union of the native
scending aorta, transverse arch, and proximal pulmonary
runk.14,15 Pulmonary homografts are usually considered t
ABLE 1. Echocardiographic NAO after stage I surgery
nivariate analysis All patients NAO P value
reoperative data
Sex NS
Male 128 52 (41%)
Female 82 28 (34%)
Age at surgical intervention
(range, 1–373 d)
NS
7 131 53 (40%)
7-13 51 17 (33%)
14 28 10 (36%)
Weight at surgical intervention
(range, 1.3–4.5 kg)
.10
3 73 22 (30%)
3 136 57 (42%)
Morphologic subgroup NS
Aortic atresia/mitral atresia 47 18 (38%)
Aortic atresia/mitral stenosis 39 14 (36%)
Aortic stenosis/mitral atresia 8 1 (13%)
Aortic stenosis/mitral stenosis 62 28 (45%)
HLHS variant 54 19 (35%)
Aortic Coarctation .032
No/not known 120 38 (32%)
Yes 90 42 (47%)
perative data
Shunt type .15
RV-PA/Sano 57 17 (30%)
BT 153 63 (41%)
Shunt size NS
3.0 mm 5 1 (20%)
3.5 mm 142 59 (42%)
4.0 mm 14 7 (50%)
5.0 mm 49 13 (27%)
esection of posterior shelf of
coarctation
.015
No 154 66 (43%)
Yes 55 13 (24%)
ortic arch augmentation .065
Autologous pericardium 30 6 (20%)
Aortic homograft 115 51 (45%)
Pulmonary homograft 53 18 (34%)
Direct connection 12 4 (33%)
Multivariate analysis Odds ratio P value
atients with aortic coarctation
Resection of posterior shelf 0.15 .001
atients without aortic
coarctation
Resection of posterior shelf 0.89 .82
AO, Neoaortic arch obstruction; HLHS, hypoplastic left heart syndrome;
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De trimmed with an aortic arch–like shape, and there is
inimal surgical bleeding through suture holes. On the
ther hand, homografts are expensive, not easy to procure,
nd are prone to calcification and potentially stenosis. Au-
ologous pericardium, however, is one of the most widely
sed materials for reconstruction in pediatric cardiac sur-
ery. It is readily available, nonimmunoreactive, and rea-
onably hemostatic. When fixed with 0.6% glutaraldehyde,
t is also easy to handle, and the risk of aneurysmal dilata-
ion is reduced.
Recently, modification of the standard Norwood proce-
ure without a homograft patch has been proposed as a
uperior alternative.7-10 Intuitively, it is attractive to assum
hat the elimination of patch material in aortic reconstruc-
ion might be associated with a lower incidence of late
ortic arch obstruction because the immunoreactive material
s not expected to grow and might lead to obstruction at the
istal end of the patch. Interestingly, nearly all aortic arch
bstruction after initial palliation of HLHS is detected in the
rst few months after repair.18,19 Moreover, previous stud-
es on patients with aortic coarctation and a hypoplastic
ortic arch have demonstrated that relief of obstruction at
he site of coarctation allows transverse arch growth.18-20
hese observations indicate that recurrent arch obstruction
fter the Norwood procedure is likely related to the techni-
al adequacy of the reconstruction rather than to a lack of
rowth of the augmented aorta. In fact, Mahle and col-
eagues21 found that in patients undergoing a Norwo
rocedure, growth of the reconstructed aorta parallels the
ate seen in the healthy population. Postmortem investiga-
ions revealed that all the growth of the reconstructed aorta
ccurs in the native tissue that makes up at least a portion of
he circumference of the aorta at every level. Furthermore,
esidual coarctation of the aorta can develop as a result of
ailure to extend the homograft around the arch.
A small-caliber neoaorta has been associated with in-
ABLE 3. Resection of the posterior coarctation shelf:
ffect modification
atients with: Number % NAO
chocardiographic gradient
Aortic coarctation  resection 31 19
Aortic coarctation  no resection 59 61
No aortic coarctation  resection 24 29
No aortic coarctation  no resection 95 32
. Need for aortic balloon angioplasty and/or
arch reconstruction
Aortic coarctation  resection 31 6
Aortic coarctation  no resection 59 42
No aortic coarctation  resection 24 17
No aortic coarctation  no resection 95 20%
AO, Neoaortic arch obstruction.ABLE 2. Arch balloon angioplasty, arch reconstruction, or
oth after stage 1 surgery
nivariate analysis All patients ABA/AR P value
reoperative data
Sex NS
Male 128 30 (23%)
Female 82 20 (24%)
ge at surgical intervention
(range, 1-373 d)
NS
7 131 35 (27%)
7–13 51 12 (24%)
14 28 3 (11%)
eight at surgical intervention
(range, 1.3-4.5 kg)
.17
3 73 13 (18%)
3 136 37 (27%)
orphologic subgroup NS
Aortic atresia/mitral atresia 47 13 (28%)
Aortic atresia/mitral stenosis 39 9 (23%)
Aortic stenosis/mitral atresia 8 1 (13%)
Aortic stenosis/mitral stenosis 62 19 (31%)
HLHS variant 54 8 (15%)
ortic coarctation .032
No/not known 120 38 (32%)
Yes 90 42 (47%)
perative data
Shunt type NS
RV-PA/Sano 57 15 (26%)
BT 153 35 (23%)
Shunt size NS
3.0 mm 5 0 (0%)
3.5 mm 142 33 (23%)
4.0 mm 14 3 (21%)
5.0 mm 49 14 (29%)
Resection of posterior shelf
of coarctation
.009
No 154 44 (29%)
Yes 55 6 (11%)
Aortic arch augmentation .12
Autologous pericardium 30 5 (17%)
Aortic homograft 115 32 (28%)
Pulmonary homograft 53 13 (25%)
Direct connection 12 0 (0%)
Aortic arch augmentation .045
Autologous tissue 42 5 (12%)
Homograft 168 45 (27%)
Multivariate analysis Odds ratio P value
atients with aortic coarctation resection
of posterior shelf 0.09 .002
atients without aortic coarctation
resection of posterior shelf 0.80 .71
BA, Arch balloon angioplasty; AR, arch reconstruction; HLHS, hypoplastic
eft heart syndrome; RV-PA, right ventricle–pulmonary artery; BT,reased mortality because of hemodynamic instability in the
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Dhort-term and aortic coarctation in long-term follow-up12
n our study, however, the presence of aortic atresia–mitral
tenosis was associated with increased early mortality but
ot with recurrent arch obstruction. This finding implies that
ith current techniques, we have been able to mitigate
ypoplastic aortic arch as a risk factor for NAO.
The existence of juxtaductal coarctation or a coarctation
helf is reported in more than 80% of the patients with
LHS, especially when the shelf of the ductal-like tissue
ocated opposite the ductus arteriosum is included.4,5 This
issue has the potential to cause late obstruction.22 However,
o standard surgical approach to this defect has been widely
ccepted. Moreover, contradictory data regarding this issue
ave been reported. Burkhart and colleagues23 have recently
eported lower arch obstruction rates in patients undergoing
he Norwood procedure with a technique that includes re-
ection of the posterior shelf. However, Griselli and asso-
iates24 have reported that the type of aortic arch re-
truction did not affect the incidence of need for arch
ntervention. In our study the presence of a preoperative
osterior shelf was significantly associated with NAO and
eed for reintervention, reoperation, or both. Furthermore,
oarctectomy significantly reduced the incidence of NAO.
his association resulted in “effect modification”; that is,
oarctectomy is particularly effective in patients with a
reoperative diagnosis of coarctation. However, echocar-
iographic determination of coarctation at the level of the
mplantation of the ductus arteriosus is very challenging
ecause of the presence of a large ductus and the subsequent
urbulent blood flow at the ductal insertion into the descend-
ng thoracic aorta. Direct inspection might also play a role
n deciding whether coarctectomy should be done. More-
ver, other factors besides resection of coarctation could be
nvolved in the development of NAO in HLHS. In fact, in
ur study the risk of NAO was higher in patients undergoing
esection of coarctation when no preoperative diagnosis of a
osterior shelf was made.
In summary, coarctectomy at the time of stage I pallia-
ion significantly reduces the incidence of NAO, especially
n patients with a preoperative diagnosis of coarctation. Use
f autologous tissue to reconstruct the arch is also associ-
ted with improved outcome. An aggressive approach to
econstruction of the aortic arch at the time of stage I
alliation is advocated.
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iscussion
r James S. Tweddell (Milwaukee, Wis). Interstage survival, as
ell as improved candidacy for stage II palliation, depends on
imiting the development of recurrent or residual lesions addressed
n the initial stage I operation, including the prevention of coronary
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Dhe development of restriction of pulmonary blood flow, and, the
ubject of this presentation, prevention of aortic arch obstruction.
The authors have reviewed a 5½-year experience with 210
atients with HLHS, with special attention to the issue of arch
bstruction. The authors identified a posterior shelf in 47% of these
10 patients, and this was taken as evidence of coarctation.
One theory of coarctation suggests there is migration of ductal
mooth muscle cells into the periductal aorta, with subsequent
onstriction and narrowing of the aortic lumen. Alternatively, in
he case of infantile coarctation, we postulate that the hemody-
amic lesion itself results in an imbalance between the larger
uctus and the smaller adjacent aorta, such that a larger portion of
he junction of these 2 structures is comprised of the ductal tissue,
nd the subsequent ductal involution results in coarctation.
Coarctation can therefore be thought of as one end of the
pectrum of HLHS, and we could postulate an even greater im-
alance in the proportion of ductus and the adjacent aorta, making
oarctation a uniform part of this anomaly. Indeed, as pointed out
n the discussion in your article, it is thought to occur in at least
0% of patients with HLHS. Prosthetic material that crosses this
rea of ductal tissue, which ultimately necroses and fibroses, will
esult in a circumferential ring of nonviable tissue that does not
row and is probably the substrate of recurrent coarctation.
The principal finding of this study was a decrease in the
ncidence of recoarctation in those patients whose posterior shelf
as resected at the time of the stage I palliation. I agree completely
ith the authors’ conclusions that excision of all ductal tissue
educes the risk of recurrent arch obstruction.
I am struck by a couple of findings in this study. First, a
osterior shelf was found in only 90 (47%) of the 210 patients.
his shelf was resected in 55 patients, of whom only 6 required
eintervention for arch obstruction. This left 35 patients with a
osterior shelf who did not undergo resection, and yet 44 addi-
ional patients had recurrent arch obstruction. Therefore some
atients who underwent a resection of the posterior shelf still
equired reintervention, and some patients who had no identifiable
helf still required reintervention.
At the Children’s Hospital of Wisconsin, we use a coarctec-
omy with interdigitation, as described by both our own group and
he group from Toronto Sick Kids Hospital. We have used this
pproach on 67 consecutive patients since July 2002. A little more
han half had aortic atresia. Survival to stage II palliation was
reater than 90%. I say this only to point out that we did not lose
significant number of patients in the interstage period, and
herefore we did not lose patients who might have experienced
rch obstruction had they survived. We have had to reintervene in
one of these patients for arch obstruction. Those data are very
imilar to the data that were reported by the group from Toronto as
ell. The technique therefore is very successful in eliminating that
nterstage problem.
Therefore I have the following questions for you. First, how do
ou know that the posterior shelf resection actually achieves the
oal of complete excision of ductal tissue? Are there other mech-
nisms of arch obstruction that could be at play here?
Dr Bautista-Hernandez. In my opinion the key feature for
eoaortic obstruction is resection of coarctation, but we also think
hat this resection plays a role in avoiding posterior or delayed p
The Journal of Thoracicoarctation, recoarctation. There might be other factors involved,
ut we did not look at those factors specifically in our studies.
Dr Tweddell. Would you care to speculate? I think you had
ome information on the type of additional tissue you used or the
ack of additional tissue?
Dr Bautista-Hernandez. Additional tissue?
Dr Tweddell. Well, you talked about the use of homograft,
ither aortic or pulmonary; autologous pericardium; or no addi-
ional prosthetic material.
Dr Bautista-Hernandez. In our conclusions we show that
utologous tissue, by means of direct connection between the
ulmonary tract and the aorta or the use of autologous pericardium,
as also associated with less recurrence of neoaortic obstruction,
nd therefore we think that autologous tissue is better—is a better
issue to use—than homografts, especially aortic homografts.
Dr Tweddell. In the patients without an obvious posterior
helf, how can you be certain that there is not some residual ductal
issue in that adjacent aortic tissue?
Dr Bautista-Hernandez. The thing is that diagnosis of a
osterior shelf by means of echocardiography is sometimes diffi-
ult because of a large ductus and the subsequent turbulent flow.
herefore, we think that echocardiography is not enough to diag-
ose a posterior shelf. Therefore, the final decision should be done
n the operating room by the surgeon, and sometimes you can see
he posterior shelf, and echocardiography has not been used to
iagnose the coarctation.
Dr Tweddell. Based on this excellent review and your presen-
ation, are you going to consider a more radical resection of the
otential ductal tissue–bearing areas in the future?
Dr Bautista-Hernandez. I think our resection is radical. What
mean is that this technique entails resection, transection of the
orta, resection of ductal tissue, counterincision into the descend-
ng thoracic aorta, and anastomosis between the aortic arch and the
escending thoracic aorta. Therefore maybe we should look at that,
ut we think that it is radical enough.
Dr Glen Van Arsdell (Toronto, Ontario, Canada). I must say
e face this issue as well and had similar obstruction until we did
ull coarctation resection.
I believed that we could not be certain that we were resecting
he entire ductal tissue and therefore made counterincisions to cut
ny potential ductal ring. We actually made 2 counterincisions,
ne posteriorly and one anterolaterally. We call the resulting
nastomosis an “interdigitating repair” (2 areas of interdigitating
amination). Like Dr Tweddell, we have not seen recurrent ob-
truction.
What I would like to talk about is transplantation. We see some
ate ventricular burnout, and those patients have one option: trans-
lantation.
It turns out that they have become sensitized to the HLA
ntigens that are present in the homografts used for arch recon-
truction. You operated on quite a number of patients with autol-
gous pericardium and found that to be favorable. Most surgeons
ould think that it is harder to work with; however, from a
ensitization perspective, it might be more favorable should later
ransplantation be required.
Can you describe to us your technique for use of autologous
ericardium in arch reconstruction?
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DDr Bautista-Hernandez. The pericardium is harvested right
fter the sternotomy and is fixed with glutaraldehyde at 0.6% for
minutes. This procedure allows us to use the pericardium. It is
asier to use, and it is easier to patch the aortic arch in this way.
herefore the description of the procedure is in the article.
Dr Van Arsdell. And bleeding and kinking issues, are there
ny extra issues in that regard?
Dr Pedro del Nido (Boston, Mass). If I could just comment
ecause this is a technical question about the glutaraldehyde. I
hink this is an important question because, obviously, the concern
s aneurysm.
It is autologous pericardium. It is fixed with 0.6% glutaralde-
yde for 10 minutes. The key here is to use as little patch as
ossible. Therefore it is only to bridge the tiny gap in those few
atients in whom direct connection of the pulmonary trunk to the
orta is not made. I think that is a critical point. We did not use
arge patches of pericardium; otherwise, you will see aneurysms.
Dr Charles D. Fraser (Houston, Tex). I have a couple of
houghts and questions related to this series, which sort of high-
ight what we believe; that is, as you have correctly pointed out,
utting autologous tissue together is the best way to repair the arch
n children.
I will say from the initial approach that I was taught by Dr
oger Mee—and that we certainly were very strong proponents of
nitially in Texas when I arrived there—we found that moving the
istal arch and proximal descending aorta together really sort of
liminated the left aortopulmonary window, and we had a lot of
rouble with the left pulmonary artery in that series of patients.
Therefore in the subsequent series of hypoblasts, we really
odified the way we did it, much akin to the way Glen Van
rsdell and Jim Tweddell have described their techniques. There-
ore I wonder what your thoughts are about that. In those patients
n whom you were able to achieve a direct anastomosis, did you
nd more trouble with the left pulmonary artery?
Dr Bautista-Hernandez. Can you repeat, please?
Dr Fraser. Well, if you bring the aorta together, you bring the
ulmonary artery up underneath the aortic arch without any inter-
ening tissue, no patch, no pericardium. Do you find that that
mpinges on the left pulmonary artery more?
Dr Bautista-Hernandez. We used that technique only in 6% of
he patients in our series. Therefore we did that overall in patients
ith favorable anatomy. What I mean is with a large pulmonary t
546 The Journal of Thoracic and Cardiovascular Surgery ● Junrtery trunk and not a diminutive aorta. Therefore we did not see
any problems with the pulmonary branches.
Dr Fraser. The other question that to me has broader impli-
ations is this: Has this experience in your Norwood population
ffected the way you handle arch hypoplasia and other lesions,
uch as transposition?
Dr Bautista-Hernandez. Yes. Dr del Nido, perhaps you would
ike to answer this.
Dr del Nido. This is a critical point, and I think Roger Mee’s
uggestion of using totally autologous tissue was very, very good,
nd we try to follow that concept whenever possible. What we find
s that it is not applicable, at least in our hands, to all patients and
hat you do need a small gusset of patch material, and in that
ituation the pericardium works well.
Has it helped us with our other arch repairs? Absolutely. I think
t has been very helpful for all arch reconstructions, including
ransposition patients with hypoplastic arch.
Dr Carlos J. Troconis (Caracas, Venezuela). Back in the late
970s and early 1980s, this issue of the posterior shelf arose from
he subclavian flap repair for coarctation of aorta. But years after,
he problem still continued, even removing the posterior shelf, as
as recommended by many authors within the technique used.
his issue was abolished after we started to perform extended
nd-to-end anastomosis for neonatal coarctation repair. Therefore
n this track, I think and agree with Dr Tweddell that we should be
ore aggressive with entire resection of the periductal tissue and
osterior shelf, trying to do end-to-end anastomosis whenever
ossible.
Dr Bautista-Hernandez. What we did was an end-to-end
nastomosis between the aortic arch and the descending thoracic
orta. That is what we already did.
Dr Carl Backer (Chicago, Ill). I think that Richard Jonas
rote an editorial about “Should we resect ductal tissue?” in the
iscussion of coarctation, and the answer is yes. That seems to be
rue for HLHS also.
I have several brief questions. How were the patients selected
or one technique or the other? Do you think there was any
election bias? Did certain surgeons prefer one technique over the
ther?
Dr Bautista-Hernandez. Yes, I think so. The decision of
hether to use homograft or autologous tissue was done based onhe surgeon’s preference, and therefore there might be a bias.
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